22545037|t|Evidence for a Common Founder and Clinical Characteristics of Japanese Families with the MAPT R406W Mutation.
22545037|a|BACKGROUND/AIM: Mutations in MAPT cause frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). Patients with the MAPT R406W mutation were reported to show phenotypic heterogeneity in different ethnic backgrounds. We here report the clinical and genetic characteristics of Japanese families with the R406W mutation. METHODS: We examined the clinical and neuroimaging features of 6 patients from three families with the R406W mutation. We determined the genotypes of intragenic MAPT single-nucleotide polymorphisms (SNPs) and the flanking microsatellite markers to search for a common founder. RESULTS: The initial symptom was memory loss with the average age at onset being 54 years. Anterograde amnesia with episodic memory impairment was the predominant phenotype. Behavioral and personality changes or parkinsonism is not a prominent feature. A brain MRI study revealed marked atrophy of the medial temporal lobe. Genetic analysis of SNPs and microsatellite markers revealed that the affected members of the three families share common genotypes. CONCLUSION: The findings of the affected members in this study, which corroborate previously reported findings of European families, suggest that the R406W mutation may represent a phenotype of predominant anterograde amnesia in FTLD-17. Our genetic data suggest that a founder effect may account for some families with the R406W mutation.
22545037	89	93	MAPT	Gene	4137
22545037	94	99	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
22545037	139	143	MAPT	Gene	4137
22545037	150	215	frontotemporal dementia with parkinsonism linked to chromosome 17	Disease	MESH:D057180
22545037	217	224	FTDP-17	Disease	MESH:D057180
22545037	227	235	Patients	Species	9606
22545037	245	249	MAPT	Gene	4137
22545037	250	255	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
22545037	431	436	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
22545037	512	520	patients	Species	9606
22545037	550	555	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
22545037	608	612	MAPT	Gene	4137
22545037	757	768	memory loss	Disease	MESH:D008569
22545037	815	834	Anterograde amnesia	Disease	MESH:D020324
22545037	840	866	episodic memory impairment	Disease	MESH:D008569
22545037	936	948	parkinsonism	Disease	MESH:D010302
22545037	1011	1046	atrophy of the medial temporal lobe	Disease	MESH:D004833
22545037	1331	1336	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
22545037	1387	1406	anterograde amnesia	Disease	MESH:D020324
22545037	1410	1417	FTLD-17	Disease	MESH:D057180
22545037	1505	1510	R406W	ProteinMutation	tmVar:p|SUB|R|406|W;HGVS:p.R406W;VariantGroup:0;CorrespondingGene:4137;RS#:63750424;CorrespondingSpecies:9606;CA#:225495
22545037	Positive_Correlation	MESH:D008569	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
22545037	Association	MESH:D057180	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
22545037	Positive_Correlation	MESH:D020324	RS#:63750424;HGVS:p.R406W;CorrespondingGene:4137
22545037	Association	MESH:D057180	4137
22545037	Association	MESH:D008569	4137
22545037	Association	MESH:D057180	4137
22545037	Association	MESH:D020324	4137

